Pharsight

EISAI R&D MANAGEMENT CO LTD PATENTS FACING OPPOSITIONS

Top patents of EISAI R&D MANAGEMENT CO LTD facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3524595B1 10 Aug, 2022 High-Purity Quinoline Derivative And Method For Manufacturing Same Aug, 2035 9
EP3265122B1 04 May, 2022 Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer Mar, 2036 5
EP3338779B1 30 Jun, 2021 Tumor Therapeutic Agent Aug, 2036 1